{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the revocation of the biologics license application (BLA) for LARTRUVO (olaratumab) injection. Eli Lilly and Co. requested withdrawal (revocation) of the biologics license application and has waived its opportunity for a hearing.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/07/17/2020-15516.html","cfr_references":[],"citation":"85 FR 43587","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The BLA is revoked as of February 25, 2020.","disposition_notes":null,"docket_ids":["Docket No. FDA-2020-N-1618"],"dockets":[],"document_number":"2020-15516","effective_on":null,"end_page":43587,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/07/17/2020-15516.xml","html_url":"https://www.federalregister.gov/documents/2020/07/17/2020-15516/eli-lilly-and-co-announcement-of-the-revocation-of-the-biologics-license-for-lartruvo","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-15516?publication_date=2020-07-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-07-17/2020-15516/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":2214,"last_updated":"2026-10-25 06:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-07-17/pdf/2020-15516.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-15516.pdf?1594903549","publication_date":"2020-07-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/07/17/2020-15516.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2020-N-1618","supporting_documents_count":0,"docket_id":"FDA-2020-N-1618","regulation_id_number":null,"title":"Eli Lilly and Co.; Announcement of the Revocation of the Biologics License for LARTRUVO","checked_regulationsdotgov_at":"2020-07-20T08:30:07Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":43587,"subtype":null,"title":"Eli Lilly and Co.; Announcement of the Revocation of the Biologics License for LARTRUVO","toc_doc":"Eli Lilly and Co.; LARTRUVO","toc_subject":"Revocation of Biologics License:\n","topics":[],"type":"Notice","volume":85}